Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
2007-002964-90Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Safinamide add-on with Placebo add-on (2 arms). Primary endpoint: Daily on time. Started Sep 2007; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-002964-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002964-90.